Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance

Affiliations

• ¹ Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
• ² Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ³ Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Genetics, Harvard Medical School, Boston, MA, USA.
• ⁴ Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
• ⁵ Department of Gastroenterology, the Second Xiangya Hospital of Central South University, Changsha, China.
• ⁶ School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
• ⁷ Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
• ⁸ Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, School of Life Sciences, Peking University, Beijing, China.
• ⁹ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. [email protected].
• ¹⁰ Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Genetics, Harvard Medical School, Boston, MA, USA. [email protected].
• ¹¹ Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. [email protected].